Education, EUGLOH, Research
SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy
… cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be severe and even lethal. … cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be severe and even lethal. … cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be severe and even lethal. …
Published on: